Metagenomi Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
MGX Nasdaq 2830 metagenomi.co

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Metagenomi Therapeutics, Inc.

Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference - May 28th, 2026 6:00 am
Metagenomi Therapeutics, Inc. (NASDAQ:MGX) Just Reported And Analysts Have Been Cutting Their Estimates - May 14th, 2026 7:42 am
Metagenomi Therapeutics (MGX) Reports Q1 Loss, Misses Revenue Estimates - May 11th, 2026 6:05 pm
Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results - May 11th, 2026 2:05 pm
Assembly Biosciences (ASMB) Reports Q1 Loss, Misses Revenue Estimates - May 7th, 2026 3:15 pm
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency - Apr 16th, 2026 5:00 am
Spotlight On 3 ASX Penny Stocks With Market Caps Under A$2B - Apr 2nd, 2026 2:02 pm
Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates - Mar 5th, 2026 3:30 pm
Metagenomi Therapeutics: Q4 Earnings Snapshot - Mar 5th, 2026 2:28 pm
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results - Mar 5th, 2026 2:05 pm
Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates - Feb 26th, 2026 3:30 pm
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference - Feb 23rd, 2026 2:05 pm
Is Metagenomi Therapeutics (NASDAQ:MGX) In A Good Position To Deliver On Growth Plans? - Feb 12th, 2026 3:47 am
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook - Jan 12th, 2026 6:30 am
Trainium3 UltraServers Now Available: Enabling Customers to Train and Deploy AI Models Faster at Lower Cost - Dec 2nd, 2025 11:30 am
Amazon Launches New AI Chip While Teasing Future Tech Collaboration With Nvidia - Dec 2nd, 2025 10:26 am
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference - Dec 1st, 2025 5:00 am
Metagenomi to Present at Jefferies Global Healthcare Conference in London - Nov 17th, 2025 6:00 am
Metagenomi, Ovid CEOs step aside; Cogent soars on ‘unprecedented’ stomach cancer data - Nov 12th, 2025 3:20 am
Metagenomi to Advance Hemophilia A Gene Therapy to Clinical Trials - Nov 11th, 2025 3:42 pm